(Q38943320)

English

5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (ΔΨm)-mediated apoptosis in hepatocellular carcinoma

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (ΔΨm)-mediated apoptosis in hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

based on heuristic

inferred from title

author name string

Xiao-Yun Hu

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Ji-Yun Liang

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Xue-Jun Guo

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Li Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Ya-Bing Guo

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

publication date

1 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Clinical and Experimental Pharmacology and Physiology

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

146-153

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Novel advancements in the management of hepatocellular carcinoma in 2008.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Gemcitabine and docetaxel for hepatocellular carcinoma: a phase II North Central Cancer Treatment Group clinical trial

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Apigenin and its impact on gastrointestinal cancers.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Apigenin Induces Apoptosis through a Mitochondria/Caspase-Pathway in Human Breast Cancer MDA-MB-453 Cells

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

A mechanism of apigenin-induced apoptosis is potentially related to anti-angiogenesis and anti-migration in human hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Apigenin induces apoptosis and impairs head and neck carcinomas EGFR/ErbB2 signaling.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Evaluation of the effects of the flavonoid apigenin on apoptotic pathway gene expression on the colon cancer cell line (HT29).

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen).

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Antioxidative characteristics and inhibition of alpha-melanocyte-stimulating hormone-stimulated melanogenesis of vanillin and vanillic acid from Origanum vulgare

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Apigenin: a promising molecule for cancer prevention

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

ROS stress in cancer cells and therapeutic implications

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Dangerous combinations: Ingestible CAM supplement use during chemotherapy in patients with ovarian cancer.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

V8, a newly synthetic flavonoid, induces apoptosis through ROS-mediated ER stress pathway in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

DEDC, a new flavonoid induces apoptosis via a ROS-dependent mechanism in human neuroblastoma SH-SY5Y cells

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Caspase-2 activation in neural stem cells undergoing oxidative stress-induced apoptosis

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Bioenergetic aspects of apoptosis, necrosis and mitoptosis

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Parthenolide-induced apoptosis of hepatic stellate cells and anti-fibrotic effects in an in vivo rat model

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Sodium fluoride induces apoptosis in mouse embryonic stem cells through ROS-dependent and caspase- and JNK-mediated pathways

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Bcl2-L-10, a novel anti-apoptotic member of the Bcl-2 family, blocks apoptosis in the mitochondria death pathway but not in the death receptor pathway

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12333

21 January 2018

Identifiers

10.1111/1440-1681.12333

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38943320&oldid=1797710270"